-
-
Call more information
660-596-2224 -
ASA Monitor May 2024, Vol. 88, 12. A 61 y/o male was admitted with acute onset of stroke. Neuroradiologic imaging confirmed a thrombotic etiology, and alteplase was administered. The patient was emergently brought to an interventional suite for definitive treatment. He was intubated by the anesthesia team consisting of an attending anesthesiologist and a CRNA. The […]
Read MoreASA Monitor May 2024, Vol. 88, 27. Researchers at the National Institutes of Health (NIH) investigated the immune system responses and microbiome changes in individuals who switched between a vegan and ketogenic (keto) diet over two-week periods. They found that the vegan diet stimulated innate immunity, while the keto diet triggered adaptive immune responses. The study […]
Read MoreASA Monitor May 2024, Vol. 88, 27. The CEREGLIDE™ 71 Intermediate Catheter with TruCourse™ from Cerenovus, Inc., a division of Johnson & Johnson MedTech, is now available in the United States. The catheter is designed for the revascularization of acute ischemic stroke patients and facilitates direct aspiration and compatible stent retriever delivery, aiding in restoring blood […]
Read MoreAuthors: Dibash Kumar Das, PhD; Steven L. Shafer, MD, FASA ASA Monitor May 2024, Vol. 88, 1–5. Since its introduction almost 40 years ago, propofol has been adopted worldwide as the intravenous anesthetic of choice, with alternatives such as ketamine and etomidate limited to unusual indications. However, propofol has several common adverse effects, including pain on injection […]
Read MoreASA Monitor May 2024, Vol. 88, 10. Your next patient is a 55-year-old man with chronic kidney disease who is presenting for kidney transplantation from a deceased donor. Your resident asks about the use of intravenous (I.V.) balanced crystalloid solution for perioperative volume resuscitation. According to a recent study, which of the following MOST likely describes […]
Read More